Search
Search Constraints
You searched for: Author/Creator Pinti, MarkLimit your search
- Pinti, Mark [remove] 1
- 5-Azacitidine (PubMED CID: 9444) -- 5-Fluorouracil (PubMED CID: 3385) -- Afatinib (PubMED CID: 10184653) -- Abemaciclib (PubMED CID: 46220502) -- Alisertib (PubMED CID: 24471867) -- Alpelisib (PubMED CID: 56649450) -- Anastrozole (PubMED CID: 2187) -- Apitolisib (PubMED CID: 25254071) -- Bleomycin (PubMED CID: 5360373) -- Brilanestrant (PubMED CID: 56941241) -- Buparlisib (PubMED CID: 16654980) -- Cabozantinib (PubMED CID: 25102847) -- Capecitabine (PubMED CID: 60953) -- Carmustine (PubMED CID: 2578) -- Cisplatin (PubMED CID: 84691) -- Cyclophosphamide (PubMED CID: 2907) -- Cytarabine (PubMED CID: 6253) -- Dactolisib (PubMED CID: 11977753) -- Daunorubicin (PubMED CID: 30323) -- Docetaxel (PubMED CID: 148124) -- Doxorubicin (PubMED CID: 31703) -- Elacestrant (PubMED CID: 23462301) -- Entinostat (PubMED CID: 4261) -- Eribulin (PubMED CID: 17755248) -- Estradiol (PubMED CID: 5757) -- Etirinotecan pegol (PubMED CID: 71300725) -- Etoposide (PubMED CID: 36462) -- Everolimus (PubMED CID: 18477728) -- Exemestane (PubMED CID: 60198) -- Fulvestrant (PubMED CID: 104741) -- Gemcitabine (PubMED CID: 60750) -- Goserelin (PubMED CID: 5311128) -- Ifosfamide (PubMED CID: 3690) -- Iniparib (PubMED CID: 9796068) -- Irinotecan (PubMED CID: 60838) -- Lapatinib (PubMED CID: 208908) -- Lenvatinib (PubMED CID: 9823820) -- Letrozole (PubMED CID: 3902) -- Leuprorelin (PubMED CID: 657181) -- Lomustine (PubMED CID: 3950) -- Methotrexate (PubMED CID: 126941) -- Mitoxantrone (PubMED CID: 4212) -- Neratinib (PubMED CID: 9915743) -- Olaparib (PubMED CID: 23725625) -- Palbociclib (PubMED CID: 122706004) -- Paclitaxel (PubMED CID: 36314) -- Pictilisib (PubMED CID: 17755052) -- Pilaralisib (PubMED CID: 56599306) -- Ribociclib (PubMED CID: 44631912) -- Rucaparib (PubMED CID: 9931954) -- Sonidegib (PubMED CID: 24775005) -- Sunitinib (PubMED CID: 5329102) -- Tamoxifen (PubMED CID: 2733526) -- Taselisib (PubMED CID: 51001932) -- Temozolomide (PubMED CID: 5394) -- Teniposide (PubMED CID: 452548) -- Topotecan (PubMED CID: 60700) -- Tucatinib (PubMED CID: 51039094) -- Veliparib (PubMED CID: 11960529) -- Vincristine (PubMED CID: 5978) -- Vinorelbine (PubMED CID: 5311497) -- Voxtalisib (PubMED CID: 49867926) -- Z-Endoxifen (PubMED CID: 10090750) 1
- 615.105 1
- ABC accelerated blood clearance -- BBB blood-brain barrier -- BCBM breast cancer brain metastases -- BTB blood-tumor barrier -- CNS central nervous system -- CDK cyclin-dependent kinase -- EPR enhanced permeation and retention -- ER estrogen receptor -- HDAC histone deacetylase -- HER2 human epidermal growth factor receptor 2 -- HR Hormone receptor -- MBCB metastatic breast cancer of the brain -- mTOR mammalian target of rapamycin -- OS overall survival -- P-gp permeability glycoprotein -- PARP poly-ADP ribose polymerase -- PEG polyethylene glycol -- PFS progression-free survival -- PI3K phosphatidylinositide 3-kinase -- PEG polyethylene glycol -- PR progesterone receptor -- SRS stereotactic radiosurgery -- T-DM1 trastuzumab emtansine -- TNBC triple negative breast cancer -- VEGF vascular endothelial growth factor -- WBRT whole-brain radiation therapy 1
- Breast cancer brain metastases -- Novel chemotherapy -- Nanoparticles -- Liposomes -- Pegylation -- Clinical trials 1
- Médicaments -- Recherche -- Périodiques 1
- Pharmacologie -- Périodiques 1
- Pharmacology -- Periodicals 1
- Research -- Periodicals 1